Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects
← catalyst calendarSponsored by Corcept Therapeutics (industry) · CORT — their whole pipeline →.
Phase
Phase 1
Status
Completed
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
18actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-09-11 | actual | When the study began enrolling |
| Primary completion | 2026-03-03 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-03-03 | actual | The whole study's end, after follow-up |
| First posted | 2025-11-20 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-13 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Healthy
Interventions
- Drug: Miricorilant Treatment A — also filed as CORT118335
- Drug: Miricorilant Treatment B — also filed as CORT118335
- Drug: Miricorilant Treatment C — also filed as CORT118335
- Drug: Miricorilant Treatment D — also filed as CORT118335
Primary outcomes
what the primary-completion date above is the date OFTime of Maximum Observed Concentration (Tmax) of Miricorilant
measured Predose and at serial timepoints up to 72 hours postdose
Maximum Observed Concentration (Cmax) of Miricorilant
measured Predose and at serial timepoints up to 72 hours postdose
Concentration at 24 Hours Postdose (C24) of Miricorilant
measured Predose and at serial timepoints up to 24 hours postdose
Area Under the Curve from Time 0 to the Time of Last Measurable Concentration (AUC[0-last]) of Miricorilant
measured Predose and at serial timepoints up to 72 hours postdose
Area Under the Curve from Time 0 Extrapolated to Infinity (AUC[0-inf]) of Miricorilant
measured Predose and at serial timepoints up to 72 hours postdose
Terminal Elimination Half-Life (T1/2) of Miricorilant
measured Predose and at serial timepoints up to 72 hours postdose
Relative Bioavailability (Frel) for Miricorilant Based on Cmax
measured Predose and at serial timepoints up to 72 hours postdose
Frel for Miricorilant based on AUC(0-last)
measured Predose and at serial timepoints up to 72 hours postdose
Frel for Miricorilant Based on AUC(0-inf)
measured Predose and at serial timepoints up to 72 hours postdose
Permalink · CORT's whole pipeline · Catalyst calendar · Every registered study · What changed